{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P55072",
      "entity_text" : "VCP",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5978",
      "entity_text" : "vincristine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The majority of cases of vincristine induced VCP have been reported in the pediatric population.1, 2 Very few cases have been reported in the adult population.1 It is also noted that vincristine induced neurotoxicity tends to be related to dose intensity and a cumulative dose effect.1 Despite the unsettled mechanism of vincristine induced neuropathy, neuroprotective and neuroregenerative treatment efforts have been attempted.",
  "reading_complete" : "2020-08-03T14:20:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:19:27Z",
  "trigger" : "induced",
  "evidence" : [ "vincristine-induced VCP" ],
  "pmc_id" : "6389462",
  "score" : 0
}